perfosfamide has been researched along with Breast Neoplasms in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.11) | 18.7374 |
| 1990's | 20 (74.07) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Dziegiel, P; Jablonska, K; Maciejczyk, A; Matkowski, R; Partynska, A; Suchanski, J; Szymczak-Kulus, K; Ugorski, M; Urbaniak, A | 1 |
| Bocci, G; Kerbel, RS; Nicolaou, KC | 1 |
| Blomqvist, C; Larsson, R; Nygren, P; Villman, K | 1 |
| Braine, HG; Clarke, B; Davidson, NE; Davis, JM; Huelskamp, AM; Noga, SJ; Ohly, K; Passos-Coelho, JL; Schepers, KG; Wright, SK | 1 |
| Crown, JP; Kritz, A; Moore, MA; Norton, L; Reich, L; Schneider, JG; Wasserheit, C; Wong, G | 1 |
| Bearman, SI; Jones, RB; Myers, S; Purdy, M; Shpall, EJ; Stemmer, SM | 1 |
| Davidson, NE; Davis, J; Huelskamp, AM; Kennedy, MJ; Noga, SJ; Ohly, K; Passos-Coelho, J | 1 |
| Colvin, OM; Gamcsik, MP; Millis, KK | 1 |
| Gurtler, J; Liebmann, J | 1 |
| Chen, G; Waxman, DJ | 1 |
| Davis, JM; Eby, LL; Noga, SJ; Schepers, KG | 1 |
| Graham, CH; Kapitain, SJ; Kerbel, RS; Kobayashi, H; Man, S; Stankiewicz, KS | 1 |
| Kuroi, K; Sato, Y; Toge, T; Yamaguchi, Y | 1 |
| Clarke, B; Davidson, NE; Davis, JM; Huelskamp, AM; Kennedy, MJ; Noga, SJ; Passos-Coelho, J; Ross, AA | 1 |
| Bast, RC; Bearman, SI; Bonner, HS; Franklin, WA; Hami, L; McCulloch, W; Peters, WP; Shaw, L; Shpall, EJ; Stemmer, SM | 1 |
| Sladek, NE; Sreerama, L | 1 |
| Bearman, SI; Cagnoni, PJ; Capizzi, R; Franklin, WA; Hami, L; Jones, RB; Ross, M; Schein, PS; Shpall, EJ | 1 |
| Ericson, SG; Fortney, J; Gibson, LF; Landreth, KS; Lynch, JP; Magro, G | 1 |
| Adams, DJ; Boal, JH; Colvin, OM; Flowers, JL; Gamcsik, MP; Ludeman, SM; Shao, KL; Springer, JB | 1 |
| Bast, RC; Houston, LL; O'Briant, KC; Peters, WP; Shpall, EJ | 1 |
| Affronti, ML; Bast, RC; Eggleston, S; Johnston, C; Jones, RB; Rosner, GL; Ross, M; Shpall, EJ; Tepperburg, M; Vandermark, R | 1 |
| Antman, KH; Eder, JP; Frei, E; Herman, TS; Holden, SA; Teicher, BA | 1 |
| Anderson, IC; Bast, RC; Edwards, S; Eggleston, S; Johnston, C; Joines, WT; Jones, RB; Ross, M; Shpall, EJ; Tepperberg, M | 1 |
| Hug, V; Johnston, D; Polyzos, A; Thames, HD | 1 |
| Finders, M; Hortobagyi, G; Hug, V; Thames, H | 1 |
| Daidone, MG; De Lena, M; Sanfilippo, O; Silvestrini, R; Varini, M; Zaffaroni, N | 1 |
6 trial(s) available for perfosfamide and Breast Neoplasms
| Article | Year |
|---|---|
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Breast Neoplasms; Cyclophosphamide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukapheresis; Leukocyte Count; Middle Aged; Platelet Count; Predictive Value of Tests; Thiotepa | 1995 |
Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Topics: Adult; Antigens, CD; Antigens, CD34; Blood Cells; Bone Marrow Cells; Bone Marrow Transplantation; Breast Neoplasms; Cell Separation; Combined Modality Therapy; Cyclophosphamide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Interleukin-1; Middle Aged; Ovarian Neoplasms; Stem Cell Factor | 1994 |
New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.
Topics: Amifostine; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Stem Cells | 1993 |
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
Topics: Adult; Amifostine; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Hematopoietic Stem Cells; Humans; Transplantation, Autologous | 1994 |
Use of amifostine in bone marrow purging.
Topics: Adult; Amifostine; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Premedication; Treatment Outcome | 1996 |
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplastic Stem Cells; Survival Rate | 1991 |
21 other study(ies) available for perfosfamide and Breast Neoplasms
| Article | Year |
|---|---|
Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Female; Glycoproteins; Humans; Membrane Transport Proteins; Mice; Paclitaxel; Prolactin | 2023 |
Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bridged-Ring Compounds; Cell Division; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Endothelium, Vascular; Epothilones; Humans; Paclitaxel; Tumor Cells, Cultured | 2002 |
Predictive value of in vitro assessment of cytotoxic drug activity in advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Survival; Cyclophosphamide; Disease Progression; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Female; Fluorometry; Fluorouracil; Humans; Methotrexate; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Quality Control; Retrospective Studies; Taxoids; Treatment Outcome; Tumor Cells, Cultured | 2005 |
Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with m
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Length of Stay; Leukocyte Count; Middle Aged; Neutrophils; Novobiocin; Recombinant Proteins; Thiotepa | 1993 |
Amifostine shortens bone marrow recovery period in breast cancer patients.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Humans; Leukocytes | 1995 |
Noninvasive detection of elevated glutathione levels in MCF-7 cells resistant to 4-hydroperoxycyclophosphamide.
Topics: Breast Neoplasms; Cell Division; Cyclophosphamide; Drug Resistance; Glutathione; Humans; Magnetic Resonance Spectroscopy; Tumor Cells, Cultured | 1995 |
Combination intraventricular therapy with thiotepa and cytarabine in meningeal carcinomatosis due to breast cancer: in vitro evidence for supra-additive cytotoxicity.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Drug Resistance; Drug Synergism; Female; Humans; Injections, Intraventricular; Meningeal Neoplasms; Middle Aged; Salvage Therapy; Thiotepa; Tumor Cells, Cultured | 1995 |
Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.
Topics: Aldehyde Dehydrogenase; Aldehydes; Breast Neoplasms; Buthionine Sulfoximine; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance; Ethacrynic Acid; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Methionine Sulfoximine | 1995 |
Comparison of progenitor cell concentration techniques: continuous flow separation versus density-gradient isolation.
Topics: Adult; Bone Marrow Cells; Bone Marrow Purging; Breast Neoplasms; Cell Count; Cell Separation; Centrifugation, Density Gradient; Child; Cyclophosphamide; Erythrocyte Count; Hematocrit; Hematopoietic Stem Cells; Humans; Indicators and Reagents; Neoplasms; United States; United States Food and Drug Administration | 1993 |
Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents.
Topics: Animals; Breast Neoplasms; Cisplatin; Cyclophosphamide; Drug Resistance; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Time Factors; Tumor Cells, Cultured | 1994 |
Modulation of suppressor cell activities by cyclophosphamide in breast cancer patients.
Topics: Breast Neoplasms; Concanavalin A; Cyclophosphamide; Female; Humans; T-Lymphocytes, Regulatory | 1994 |
Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
Topics: Adult; Bone Marrow; Bone Marrow Purging; Breast Neoplasms; Cyclophosphamide; Female; Humans; Middle Aged; Prospective Studies; Tumor Stem Cell Assay | 1994 |
Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Topics: Adenocarcinoma; Aldehyde Dehydrogenase; Benzaldehydes; Breast Neoplasms; Cell Line; Cyclophosphamide; Drug Resistance; Gastric Mucosa; Gene Expression Regulation, Enzymologic; Humans; Hydrogen-Ion Concentration; Isoenzymes; NAD; NADP; Subcellular Fractions; Temperature | 1993 |
Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 1999 |
Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide.
Topics: Acrolein; Antineoplastic Agents, Alkylating; Aziridines; Breast Neoplasms; Cell Count; Cell Nucleus; Cell Survival; Cyclophosphamide; Humans; Indicators and Reagents; Kinetics; Magnetic Resonance Spectroscopy; Tumor Cells, Cultured | 2000 |
Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres.
Topics: Antibodies, Monoclonal; Bone Marrow; Bone Marrow Examination; Bone Marrow Transplantation; Bone Neoplasms; Breast Neoplasms; Cell Separation; Clone Cells; Cyclophosphamide; Humans; Immunotoxins; In Vitro Techniques; Magnetics; Microspheres; Transplantation, Autologous; Tumor Stem Cell Assay | 1991 |
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Cell Hypoxia; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Fluorocarbons; Half-Life; Humans; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Thiotepa; Tumor Cells, Cultured | 1990 |
Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
Topics: Antibodies, Monoclonal; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Breast Neoplasms; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Female; Humans; Magnetics; Microspheres; Transplantation, Autologous; Tumor Cells, Cultured | 1990 |
Chemoresistance is not a cause of the apparent failure of adjuvant chemotherapy in postmenopausal women.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Fluorouracil; Humans; Menopause; Middle Aged; Tumor Stem Cell Assay; Vinblastine | 1988 |
Chemosensitivities of human clonogenic breast tumor cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Humans; In Vitro Techniques; Tumor Stem Cell Assay | 1986 |
Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Female; Humans; Mastectomy; RNA, Neoplasm; Tumor Stem Cell Assay; Vincristine | 1985 |